As on Thursday, Roivant Sciences Ltd (NASDAQ: ROIV) got off with the flyer as it spiked 4.37% to $19.58, before settling in for the price of $18.76 at the close. Taking a more long-term approach, ROIV posted a 52-week range of $8.73-$18.95.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -99.51%. Meanwhile, its Annual Earning per share during the time was -99.51%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -430.71%. This publicly-traded company’s shares outstanding now amounts to $682.23 million, simultaneously with a float of $415.35 million. The organization now has a market capitalization sitting at $13.37 billion. At the time of writing, stock’s 50-day Moving Average stood at $15.17, while the 200-day Moving Average is $12.00.
Roivant Sciences Ltd (ROIV) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Roivant Sciences Ltd’s current insider ownership accounts for 39.18%, in contrast to 64.09% institutional ownership. According to the most recent insider trade that took place on Oct 15 ’25, this organization’s President & Immunovant CEO sold 414,683 shares at the rate of 16.93, making the entire transaction reach 7,020,583 in total value, affecting insider ownership by 1,504,959. Preceding that transaction, on Oct 16 ’25, Company’s President & Immunovant CEO sold 318,282 for 17.05, making the whole transaction’s value amount to 5,426,708. This particular insider is now the holder of 1,504,959 in total.
Roivant Sciences Ltd (ROIV) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
Roivant Sciences Ltd’s EPS decrease for this current 12-month fiscal period is -430.71% and is forecasted to reach -1.39 in the upcoming year.
Roivant Sciences Ltd (NASDAQ: ROIV) Trading Performance Indicators
Let’s observe the current performance indicators for Roivant Sciences Ltd (ROIV). It’s Quick Ratio in the last reported quarter now stands at 40.54. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 575.58.
In the same vein, ROIV’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.70, a figure that is expected to reach -0.32 in the next quarter, and analysts are predicting that it will be -1.39 at the market close of one year from today.
Technical Analysis of Roivant Sciences Ltd (ROIV)
Through scrutinizing the latest numbers posted by the [Roivant Sciences Ltd, ROIV], it can be observed that its last 5-days Average volume of 9.08 million was better the volume of 6.38 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 86.92% While, its Average True Range was 86.32.
Raw Stochastic average of Roivant Sciences Ltd (ROIV) in the period of the previous 100 days is set at 99.05%, which indicates a major rise in contrast to 97.69% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.56 that was higher than 0.38 volatility it exhibited in the past 100-days period.
